DK192588A - Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse - Google Patents
Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelseInfo
- Publication number
- DK192588A DK192588A DK192588A DK192588A DK192588A DK 192588 A DK192588 A DK 192588A DK 192588 A DK192588 A DK 192588A DK 192588 A DK192588 A DK 192588A DK 192588 A DK192588 A DK 192588A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolaldehydes
- preparation
- acid addition
- addition salts
- acceptable acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873713725 DE3713725A1 (de) | 1987-04-24 | 1987-04-24 | Pyrrolaldehyde, ihre herstellung und ihre verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
DK192588D0 DK192588D0 (da) | 1988-04-08 |
DK192588A true DK192588A (da) | 1988-10-25 |
Family
ID=6326209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK192588A DK192588A (da) | 1987-04-24 | 1988-04-08 | Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0287988A3 (da) |
JP (1) | JPS63280059A (da) |
KR (1) | KR880012545A (da) |
DE (1) | DE3713725A1 (da) |
DK (1) | DK192588A (da) |
HU (1) | HU199787B (da) |
IL (1) | IL85824A (da) |
PT (1) | PT87286B (da) |
ZA (1) | ZA882852B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4020851A1 (de) * | 1990-06-29 | 1992-01-02 | Cassella Ag | 2-(aminoalkyl)-pyrrolaldehyde, verfahren zu ihrer herstellung und ihre verwendung |
DE4211531A1 (de) * | 1992-04-06 | 1993-10-07 | Cassella Ag | Verfahren zur Herstellung von Pyrrolderivaten |
KR102495650B1 (ko) * | 2017-04-12 | 2023-02-02 | 에프. 호프만-라 로슈 아게 | 알데히드 함유 표적 분자의 라벨링 방법 |
JP7343170B2 (ja) * | 2017-05-12 | 2023-09-12 | ボード オブ トラスティーズ オブ ザ サザン イリノイ ユニバーシティ オン ビハーフ オブ サザン イリノイ ユニバーシティ エドワーズビル | 3,4,5-三置換-1,2,4-トリアゾールおよび3,4,5-三置換-3-チオ-1,2,4-トリアゾール、ならびにそれらの使用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4180660A (en) * | 1977-10-04 | 1979-12-25 | Yeda Research And Development Co. Ltd. | Cephalosporin derivatives |
DE3527791A1 (de) * | 1985-08-02 | 1987-02-12 | Cassella Ag | 2,5-dimethylpyrrolderivate, ihre herstellung und ihre verwendung |
DE3531504A1 (de) * | 1985-09-04 | 1987-03-12 | Basf Ag | 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel |
-
1987
- 1987-04-24 DE DE19873713725 patent/DE3713725A1/de not_active Withdrawn
-
1988
- 1988-03-23 IL IL85824A patent/IL85824A/xx not_active IP Right Cessation
- 1988-04-08 DK DK192588A patent/DK192588A/da not_active Application Discontinuation
- 1988-04-18 EP EP88106137A patent/EP0287988A3/de not_active Ceased
- 1988-04-21 PT PT87286A patent/PT87286B/pt not_active IP Right Cessation
- 1988-04-22 ZA ZA882852A patent/ZA882852B/xx unknown
- 1988-04-22 KR KR1019880004569A patent/KR880012545A/ko not_active Application Discontinuation
- 1988-04-22 HU HU882056A patent/HU199787B/hu not_active IP Right Cessation
- 1988-04-22 JP JP63098440A patent/JPS63280059A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3713725A1 (de) | 1988-11-17 |
PT87286B (pt) | 1992-08-31 |
ZA882852B (en) | 1988-12-28 |
EP0287988A3 (de) | 1990-07-18 |
IL85824A (en) | 1992-09-06 |
KR880012545A (ko) | 1988-11-28 |
HU199787B (en) | 1990-03-28 |
EP0287988A2 (de) | 1988-10-26 |
PT87286A (pt) | 1988-05-01 |
DK192588D0 (da) | 1988-04-08 |
IL85824A0 (en) | 1988-09-30 |
HUT46890A (en) | 1988-12-28 |
JPS63280059A (ja) | 1988-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK108586D0 (da) | Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
DK180288A (da) | 5-substituerede quinolon- og naphthyridoncarboxylsyrederivater, deres fremstilling og anvendelse | |
DK374289A (da) | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse | |
DK605489D0 (da) | Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse | |
DK519189D0 (da) | Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
NO871526D0 (no) | Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling. | |
DK266486D0 (da) | Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK29287D0 (da) | 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse | |
DK521986D0 (da) | Benzylaminderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som fungicider | |
NO891749D0 (no) | Syreaddisjonssalter, deres fremstilling og anvendelse. | |
DK192788D0 (da) | Substituerede anilidderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK144885A (da) | Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
DK157387A (da) | Substiturede 4-amino-3-hydroxysmoersyrederivater ogfysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
DK543788D0 (da) | Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
DK179786D0 (da) | (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika | |
DK192588D0 (da) | Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK238089D0 (da) | Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK523289A (da) | 2,3,5,6-tetrahydro(1,3,6)triazocino(1,2-a)benzim- idazoler eller farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse | |
DK299983D0 (da) | Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK291986A (da) | 10alfa-methoxy-6-methylergolinderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK504386D0 (da) | Gonadoliberinanaloge og farmaceutisk acceptable syreadditionssalte, deres fremstilling og anvendelse | |
DK404386D0 (da) | Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
DK292086D0 (da) | 2-halogennicergolinderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK559388D0 (da) | Anthracyclinderivater og farmaceutisk uskadelige syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK120088D0 (da) | Cephalosporinderivater og fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |